Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.05
-0.15 (-1.23%)
May 29, 2026, 1:55 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.13 billion as of May 29, 2026. Its market cap has decreased by -31.55% in one year.
Market Cap
7.13B
Enterprise Value
3.59B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.05
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.13B, a decrease of -68.89%. That is a compound annual growth rate of -34.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 7.13B | -20.19% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 10.04B |
| Gongwin Biopharm Holdings | 9.05B |
| PharmaEngine | 7.77B |
| Adimmune | 7.17B |
| TaiGen Biopharmaceuticals Holdings | 6.42B |
| Savior Lifetec | 5.88B |
| Sinphar Pharmaceutical | 5.82B |
| Mycenax Biotech | 5.65B |